tiprankstipranks
Lisata Therapeutics (LSTA)
NASDAQ:LSTA
US Market

Lisata Therapeutics (LSTA) Income Statement

Compare
1,032 Followers

Lisata Therapeutics Income Statement

Last quarter (Q3 2024), Lisata Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Lisata Therapeutics's net income was $-4.93M. See Lisata Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 121.37M$ 0.00$ 0.00$ 0.00
Gross Profit
$ -189.00K$ 63.77M$ -55.00K$ -63.00K$ -65.00K
Operating Expenses
$ 25.71M$ 57.60M$ 29.05M$ 19.14M$ 20.09M
Depreciation and Amortization
$ 189.00K$ 69.00K$ 55.00K$ 63.00K$ 65.00K
EBITDA
$ -25.52M$ -115.20M$ -29.00M$ -19.08M$ -20.03M
Operating Income
$ -25.71M$ -57.60M$ -29.05M$ -19.14M$ -20.09M
Other Income/Expenses
$ 2.54M$ 897.00K$ 76.00K$ 132.00K$ 740.00K
Pretax Income
$ -23.17M$ -56.70M$ -28.97M$ -19.01M$ -19.35M
Net Income
$ -20.84M$ -54.23M$ -27.47M$ -8.14M$ -20.10M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.58$ -10.47$ -7.45$ -7.91$ -29.20
Diluted EPS
$ -2.58$ -10.47$ -7.45$ -7.91$ -29.20
Weighted Average Shares Outstanding
8.07M 5.18M 3.69M 1.03M 688.33K
Weighted Average Shares Outstanding (Diluted)
8.07M 5.18M 3.69M 1.03M 688.33K
Currency in USD

Lisata Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis